Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05876299 · ClinicalTrials.gov registry record · NA
The Anabolic Properties of a Lipid-rich Pork Matrix
A NA study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05876299 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 16 participants.
The verdict
NCT05876299, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The amount and quality of skeletal muscle mass determines physical performance, but also a significant contributor to metabolic health. As such, the maintenance of skeletal muscle mass is relevant across the lifespan to remain active in family and community life. Food ingestion, particularly protein, is one of the main anabolic to skeletal muscle tissue by stimulating muscle protein synthesis rates. There have been multiple attempts to identify specialized performance nutrition products (e.g., various isolated protein powders) to maximize the anabolic properties of dietary protein on muscle. Our research group, however, has advocated for a food focus approach to meet dietary protein requirements. Particularly, we propose that whole foods demonstrate food matrix effects (nutrient-nutrient interactions) that creates a greater anabolic action on muscle beyond what amino acids can create alone. Therefore, the objective of this study is to identify the anabolic properties of consuming lipid-rich pork products when compared to their leaner counter-parts. Our working hypothesis that the ingestion of 84% or 96% lean ground pork condition will stimulate a greater increase in muscle protein synthesis rates compared to an isocaloric carbohydrate beverage in healthy adults. We further hypothesize that the ingestion of 84% lean pork will augment the stimulation of muscle protein synthesis rates to a greater extent than 96% lean ground pork. To achieve our objective, we will recruit 15 healthy men and women (20-50 y) to receive prime-constant infusions to directly measure muscle protein synthesis rates before and after treatment ingestion using our lab's established methods.
Interventions
- OTHER 95.1% Lean Pork
- OTHER 81.16% Lean Pork
- OTHER Carbohydrate Beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2023-07-15 |
| Est. Completion | 2024-04-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05876299
The ClinicalTrials.gov registry entry for NCT05876299 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 95.1% Lean Pork is the first listed.
NCT05876299 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05876299 about?
NCT05876299 is a clinical study titled "The Anabolic Properties of a Lipid-rich Pork Matrix". The amount and quality of skeletal muscle mass determines physical performance, but also a significant contributor to metabolic health. As such, the maintenance of skeletal muscle mass is relevant across the lifespan to remain active in family and community life. Food ingestion, particularly protein...
What is the current status of trial NCT05876299?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2023-07-15. Estimated completion is 2024-04-09.
What interventions are being tested in trial NCT05876299?
The interventions under investigation include: 95.1% Lean Pork (OTHER), 81.16% Lean Pork (OTHER), Carbohydrate Beverage (OTHER).
Who is sponsoring clinical trial NCT05876299?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.